Exploring Transcriptome
Track 3: Exploring Transcriptome
While exploring the complexity of the Transcriptome, the basic protocol of the identification of long stress-induced non-coding transcripts is followed. Non-coding RNAs (ncRNAs) are functional RNA molecules that are transcribed from DNA but are not translated into proteins. Functional Impact of Non-Coding RNA (ncRNA) involves regulation of gene expression at the transcriptional and post-transcriptional level. Those ncRNAs that appear to be involved in epigenetic processes can be divided into two main groups; the short ncRNAs (<30 nts) and the long ncRNAs (>200 nts). Long noncoding RNAs (lncRNAs) have gained widespread attention in recent years as a potentially new and crucial layer of biological regulation. Long noncoding RNA (lncRNAs) biochemically resemble mRNAs posited by Jacob and Monod, yet do not template protein synthesis. Rather, lncRNAs functioning as RNA genes to orchestrate genetic regulatory outputs. Today, lncRNA transcripts have emerged as a cryptic, but critical layer in the genetic regulatory code. It has been implicated in a range of developmental processes and diseases in which Long ncRNAs target proteins to specific genomic loci to affect transcription patterns. It also modulates the activity of protein-binding partners. They also act as precursors for small RNAs. Analysis of the transcriptome on neurological basis can be done under the title of profiling microRNAs and circular RNAs in brain. Here we can find out how the genomic basis is responsible for the behavioural changes through neurological basis. Even this phenomenon can be controlled through Regulation of Transcriptional Heterogeneity. The basic strategy behind the all this mechanism comes from the molecular level which contain Chromatin and Histone Protein.
John L. Rinn is the Alvin and Esta Star Associate professor of Stem Cell and Regerative Biology at Harvard University and Medical School and Senior Associate Member of the Broad Institute. Our research aims to understand the role of long non-coding RNAs (lncRNAs) in establishing the distinct epigenetic states of adult and embryonic cells and their misregulation in diseases such as cancer.
Relevant Conferences:
International Conference on Nucliec Acids, August 4-6, 2016 Seattle, USA; World Congress on Amino Acids and Proteins, December 8-9, 2016, Baltimore, USA; International Conference on Next Generation Sequencing, July 21-22, 2016, Berlin, Germany; 2nd International Conference on Transcriptomics September 12-14, 2016 Philadelphia, USA; 6th International Conference & Expo on Proteomics, March 31-Apr 2, 2016, Atlanta, USA; Noncoding RNAs and Cancer, December 4 - 7, 2015, Boston, USA; Chromatin, Noncoding RNAs in Health and Disease, February 21-24, 2016, New Mexico, USA; Non-coding RNAs and RNAP II Regulation in Development and Disease, March 29, 2016, Texas, USA; RNA UK 2016, January 29-31, 2016, Lake District, UK; Small RNA Silencing: Little Guides, Big Biology, January 24-28, 2016.
- Non-Coding RNA
- Long Non-Coding Transcripts
- Functional impact of non-coding RNA (ncRNA)
- microRNAs Profiling
- Circular RNAs
- Regulation of Transcriptional Heterogeneity
- Chromatin and Histone protein
Related Conference of Exploring Transcriptome
International Conference on Metabolism Transcription and Disease
International Conference on Chromatin and Epigenetics
International Conference on Epitranscriptome
Transcriptional Regulation in Development and Disease
3rd Annual Symposium on RNA Science Epitranscriptomics
International Conference on Chromatin Non-coding RNAs and RNAP II Regulation in Development and Disease
21st International Chromosome Conference
International Conference on Genome Editing and Gene Modulation Congress
International Conference on Transcription and Chromatin
International Conference on Plant Epigenetics From Genotype to Phenotype
International Conference on Understanding the Function of Human Genome Variation
Genome Editing and Gene Modulation Congress 2016
International Conference on Genome Editing and Engineering
International Conference on Gene transcription in yeast
Heart Failure Genetics Genomics and Epigenetics
Exploring Transcriptome Conference Speakers
Recommended Sessions
- Cancer Transcriptomics: Integrative & Computational Approaches
- Clinical Applications & Related Disorders
- Diagnosis & Applications of RNA-Seq
- Epigenetics
- Exploring Transcriptome
- Expression Profiling
- Human Transcriptomics
- NGS Technologies
- Ocular Transcriptomics
- Relation with OMICS Sciences
- RNA Editing & Interference: Interplay
- Single Cell Transcriptomics
- Transcriptional Regulation & Attenuation
- Transcriptome analysis & Gene Expression
- Transcriptome Technologies Market
- Transcriptomics & Proteomics in Microorganisms
- Transcriptomics & Proteomics in Plants
- Transcriptomics Case Reports
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Drug Delivery Systems for Metabolic Therapy - DRUG CHEMISTRY CONF 2026 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomarker-Guided Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Chemical Biology Tools in Metabolic Research - DRUG CHEMISTRY CONF 2026 (France)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Drug Design and Molecular Modeling - DRUG CHEMISTRY CONF 2026 (France)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Drug Resistance and Therapeutic Durability - DRUG CHEMISTRY CONF 2026 (France)
- Enzyme Modulation Approaches in Antidiabetic Drug Design - DRUG CHEMISTRY CONF 2026 (France)
- Epigenetic Regulation and Small-Molecule Therapeutics - DRUG CHEMISTRY CONF 2026 (France)
- Future Directions in Drug Chemistry for Diabetes Management - DRUG CHEMISTRY CONF 2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Lipid Chemistry and Metabolic Regulation - DRUG CHEMISTRY CONF 2026 (France)
- Medicinal Chemistry Strategies for Metabolic Disorders - DRUG CHEMISTRY CONF 2026 (France)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Natural Product Chemistry in Diabetes Drug Discovery - DRUG CHEMISTRY CONF 2026 (France)
- Oxidative Stress Modulation through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Peptide and Protein-Based Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Pharmacokinetics and Drug Metabolism Studies - DRUG CHEMISTRY CONF 2026 (France)
- Prodrug Design and Chemical Activation Strategies - DRUG CHEMISTRY CONF 2026 (France)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Regulatory Chemistry and Drug Safety Assessment - DRUG CHEMISTRY CONF 2026 (France)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- Structure–Activity Relationship Studies in Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Synthetic Chemistry Innovations in Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Targeting Pancreatic Function through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Translational Drug Chemistry from Bench to Clinic - DRUG CHEMISTRY CONF 2026 (France)
